Filing Flows › Chemours (CC) › Q2 2025
Chemours (CC) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 5, 2025
Chemours (CC) reported revenue of $1.6B for the second quarter 2025 (Q2 2025), +4% from a year earlier and +18% from the quarter before. Operating margin was -16.1%, net loss $379M (23.5% of revenue).
Chemours, Q2 2025: revenue $1.6B (+4% year over year), operating margin -16.1%, net loss $379M, operating cash flow $93.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6B | +18% | +4% |
| Operating profit | −$260M | — | — |
| Net earnings | −$379M | — | — |
| Operating cash flow | $93.0M | — | — |
| Free cash flow | $50.0M | — | — |
What changed
Revenue was $1.6B in Q2 2025, up 4% year over year and up 18% from the previous quarter. All Segments was the largest line at 99% of revenue. All Segments added $0.06B year over year (up 4%), 97% of the total change.
Gross margin was 17.2%, down 2.6 points from a year earlier. Operating costs exceeded revenue by $0.26B, an operating margin of -16.1%. Operating expenses grew 125% against revenue growth of 4%. The fastest-growing cost line was SG&A (+175%). The quarter ended with a net loss of $0.38B, wider than the previous quarter's $4.0M loss.
Operating cash flow was $0.09B. Non-cash charges added back $0.09B of depreciation and $0.01B of share-based compensation. Working capital and other items added $0.37B. Capital expenditures of $0.04B left free cash flow of $0.05B.
Questions
What was Chemours' revenue in the second quarter 2025?
Chemours (CC) reported revenue of $1.6B for the second quarter 2025 (Q2 2025), +4% from a year earlier and +18% from the quarter before.
Was Chemours profitable in the second quarter 2025?
Operating loss was $260M (-16.1% of revenue) and net loss $379M.
Source: Chemours 10-Q on SEC EDGAR.